More than 122,000 cases of Gatorade were pulled in 37 states after labels failed to disclose Yellow 5 and Yellow 6. Food dye allergies are rare, but regulators still require disclosure because reactions can be serious.
The herbal drug is sold in gas stations, corner stores and online across much of the country, leaving officials to assemble a patchwork of bans and regulations.
The FDA advises shoppers not to eat the recalled 22-ounce Bettergoods Authentic Italian Lemon Alfredo Fettuccine, sold at Walmart stores nationwide, because of possible listeria contamination.
Demand for off-label testosterone therapy is climbing among women seeking relief from menopause symptoms, but patients report denials, delays and insurance obstacles as the FDA prepares to weigh the evidence.
Michigan health officials on Thursday reported 14,718 cyclosporiasis cases and 366 hospitalizations as of Sept. 3, an increase of 208 illnesses over the prior week, as federal investigators continue to probe the largest U.S. foodborne outbreak in recent years.
The Pentagon has issued clinical rules for a mandatory testosterone screening program covering service members 30 and older, putting Defense Secretary Pete Hegseth's contested policy into effect with immediate impact.
The FDA has granted Juul Labs marketing authorization for Juul2, a connected e-cigarette with optional age-verification technology and updated tobacco and menthol cartridges, handing the embattled company a rare regulatory win after years of legal scrutiny.
Mesoblast reported $115 million in fiscal 2026 net revenue, driven by the first full year of RYONCIL sales, while advancing pivotal trials in adult GVHD, chronic low back pain, and Duchenne muscular dystrophy.
A new MassBio report says seed and Series A financing for Massachusetts biotech startups are moving in opposite directions, as investors favor more advanced drug prospects and the earliest companies with the riskiest science struggle to secure venture support.
Two rapid-fire outbreaks tied to Taylor Farms have laid bare how heavily the U.S. relies on Mexican produce and how hard regulators are struggling to keep imported food safe.
Certain salsas, guacamole, pico de gallo and prepared jalapeño items sold at Whole Foods are being recalled after a Mexican pepper supplier was linked to a multistate salmonella outbreak.
NeuroPace raised its 2026 revenue and adjusted EBITDA guidance after second-quarter revenue rose 17% to $22.8 million, while the company continues to work with the FDA on a potential expansion of its RNS System into idiopathic generalized epilepsy.
Oncocyte said its FDA review for the GraftAssureDx kidney-transplant rejection test remains on track, while CFO Andrea James signaled quarterly cash burn has peaked. The company is also preparing for a commercial push in the U.S. and Europe.
The California produce supplier pulled prepared foods with jalapeños from retailers after a pepper distributor's recall, as federal investigators track an outbreak that has sickened 345 people across 27 states.
One health advocate called nicotine pouches a “profound risk” for young people.
Michigan health officials reported more than 9,250 cases of cyclosporiasis on Monday, a jump of over 1,000 cases in three days, as the foodborne illness outbreak tied to shredded iceberg lettuce from Mexico continues to grow. At least 160 people have been hospitalized, though no deaths have been reported. The investigation now spans nine states, with federal regulators widening their probe amid new political scrutiny.
A little-known FDA advisory committee is meeting this week to decide whether to allow compounding pharmacies to dispense certain peptides widely used for wellness and recovery. The votes so far show narrow support for several compounds, signaling a potential shift in regulation under the second Trump administration.
The Food and Drug Administration is probing a new cyclosporiasis outbreak that has sickened at least 72 people, separate from the larger Taylor Farms lettuce-linked outbreak that has already infected more than 1,640 individuals.
Ocular Therapeutix (NASDAQ:OCUL) confirmed it remains on schedule to submit a New Drug Application for AXPAXLI in wet age-related macular degeneration in the fourth quarter, following what CEO Dr. Pravin Dugel described as formal alignment with the FDA on the submission package.
The U.S. Food and Drug Administration confirmed a positive test for cyclospora in shredded iceberg lettuce from Taylor Farms, though the company says it is not included in the current recall.
